Oritavancin 400mg powder for solution for infusion vials

SNOMED code
40651511000001105
Active compound
Oritavancin
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
✅ Yes
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Oritavancin diphosphate, ID: 704655001 — 400 mg based on base substance
Form & Route
solutioninfusion.intravenous
Powder for solution for infusion, Intravenous
Controlled drug
No Controlled Drug Status

Products

Tenkasi 400mg powder for concentrate for solution for infusion vials (A. Menarini Farmaceutica Internazionale SRL)

in short Tenkasi 400mg pdr for concentrate for inf vials

Tenkasi 400mg powder for concentrate for solution for infusion vials

SNOMED code
40637511000001103
Supplier
A. Menarini Farmaceutica Internazionale SRL
Licensed as
Medicines - MHRA/EMA
Availability restrictions
None
Licensed route
Intravenous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Tenkasi 400mg powder for concentrate for solution for infusion vials (A. Menarini Farmaceutica Internazionale SRL) 3 vial
40637611000001104   ref. pack
💯 Available

Legal category: POM
5038227000058
NHS Indicative Price
£1,500
• Hospital
  • • Prescription Charges

Reference packs

Oritavancin 400mg powder for solution for infusion vials 3 vial
SNOMED code
40637411000001102
Quantity and unit
3 vial
Packs